153 related articles for article (PubMed ID: 26818100)
1. Combined image guided monitoring the pharmacokinetics of rapamycin loaded human serum albumin nanoparticles with a split luciferase reporter.
Wang F; Yang K; Wang Z; Ma Y; Gutkind JS; Hida N; Niu G; Tian J
Nanoscale; 2016 Feb; 8(7):3991-4000. PubMed ID: 26818100
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and biodistribution of human serum albumin-TIMP-2 fusion protein using near-infrared optical imaging.
Lee MS; Kim YH; Kim YJ; Kwon SH; Bang JK; Lee SM; Song YS; Hahm DH; Shim I; Han D; Her S
J Pharm Pharm Sci; 2011; 14(3):368-77. PubMed ID: 21962154
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin/DiR loaded lipid-polyaniline nanoparticles for dual-modal imaging guided enhanced photothermal and antiangiogenic combination therapy.
Wang J; Guo F; Yu M; Liu L; Tan F; Yan R; Li N
J Control Release; 2016 Sep; 237():23-34. PubMed ID: 27388755
[TBL] [Abstract][Full Text] [Related]
4. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
Lee BS; Park K; Park S; Kim GC; Kim HJ; Lee S; Kil H; Oh SJ; Chi D; Kim K; Choi K; Kwon IC; Kim SY
J Control Release; 2010 Oct; 147(2):253-60. PubMed ID: 20624433
[TBL] [Abstract][Full Text] [Related]
5. Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo.
Shi P; Aluri S; Lin YA; Shah M; Edman M; Dhandhukia J; Cui H; MacKay JA
J Control Release; 2013 Nov; 171(3):330-8. PubMed ID: 23714121
[TBL] [Abstract][Full Text] [Related]
6. PET/NIRF/MRI triple functional iron oxide nanoparticles.
Xie J; Chen K; Huang J; Lee S; Wang J; Gao J; Li X; Chen X
Biomaterials; 2010 Apr; 31(11):3016-22. PubMed ID: 20092887
[TBL] [Abstract][Full Text] [Related]
7. Core-shell polymeric nanoparticles co-loaded with photosensitizer and organic dye for photodynamic therapy guided by fluorescence imaging in near and short-wave infrared spectral regions.
Chepurna OM; Yakovliev A; Ziniuk R; Nikolaeva OA; Levchenko SM; Xu H; Losytskyy MY; Bricks JL; Slominskii YL; Vretik LO; Qu J; Ohulchanskyy TY
J Nanobiotechnology; 2020 Jan; 18(1):19. PubMed ID: 31973717
[TBL] [Abstract][Full Text] [Related]
8. Near-infrared dye bound albumin with separated imaging and therapy wavelength channels for imaging-guided photothermal therapy.
Chen Q; Wang C; Zhan Z; He W; Cheng Z; Li Y; Liu Z
Biomaterials; 2014 Sep; 35(28):8206-14. PubMed ID: 24957292
[TBL] [Abstract][Full Text] [Related]
9. Human Serum Albumin Nanoparticles as a Novel Delivery System for Cabazitaxel.
Zhou G; Jin X; Zhu P; Yao JU; Zhang Y; Teng L; Lee RJ; Zhang X; Hong W
Anticancer Res; 2016 Apr; 36(4):1649-56. PubMed ID: 27069142
[TBL] [Abstract][Full Text] [Related]
10. Engineering of near IR fluorescent albumin nanoparticles for in vivo detection of colon cancer.
Cohen S; Margel S
J Nanobiotechnology; 2012 Aug; 10():36. PubMed ID: 22891637
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic biodistribution of polylactide nanoparticles.
Chaney EJ; Tang L; Tong R; Cheng J; Boppart SA
Mol Imaging; 2010 Jun; 9(3):153-62. PubMed ID: 20487681
[TBL] [Abstract][Full Text] [Related]
12. Preparation and Evaluation of in vitro Self-assembling HSA Nanoparticles for Cabazitaxel.
Qu N; Sun Y; Xie J; Teng L
Anticancer Agents Med Chem; 2017; 17(2):294-300. PubMed ID: 27225451
[TBL] [Abstract][Full Text] [Related]
13. Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo.
Tang QS; Chen DZ; Xue WQ; Xiang JY; Gong YC; Zhang L; Guo CQ
Int J Nanomedicine; 2011; 6():3077-85. PubMed ID: 22163161
[TBL] [Abstract][Full Text] [Related]
14. Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.
Huynh AS; Estrella V; Stark VE; Cohen AS; Chen T; Casagni TJ; Josan JS; Lloyd MC; Johnson J; Kim J; Hruby VJ; Vagner J; Morse DL
Mol Pharm; 2016 Feb; 13(2):534-44. PubMed ID: 26713599
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
16. A non-intrusive evaluation method for tumor-targeting characteristics of nanomedicines based on in vivo near-infrared fluorescence imaging.
Liu H; Marquez RT; Wu X; Li K; Vadlamani S; Li S; Wang Y; Xu L; Wu D
J Mater Chem B; 2019 Aug; 7(31):4751-4757. PubMed ID: 31389969
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting.
Gong G; Zhi F; Wang K; Tang X; Yuan A; Zhao L; Ding D; Hu Y
Nanotechnology; 2011 Jul; 22(29):295603. PubMed ID: 21673386
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
Jiao Y; Sun Y; Tang X; Ren Q; Yang W
Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
[TBL] [Abstract][Full Text] [Related]
19. Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel.
Yin T; Cai H; Liu J; Cui B; Wang L; Yin L; Zhou J; Huo M
Eur J Pharm Sci; 2016 Feb; 83():79-87. PubMed ID: 26699227
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-sensitive gemcitabine conjugated albumin nanoparticles as a versatile theranostic nanoplatform for pancreatic cancer treatment.
Han H; Wang J; Chen T; Yin L; Jin Q; Ji J
J Colloid Interface Sci; 2017 Dec; 507():217-224. PubMed ID: 28800445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
